haloperidol has been researched along with fauc 213 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boeckler, F; Gmeiner, P; Lanig, H | 1 |
| Boeckler, F; Gmeiner, P; Hocke, C; Hübner, H; Kuwert, T; Prante, O; Salama, I; Utz, W | 1 |
| Hopkins, CR; Lindsley, CW | 1 |
1 review(s) available for haloperidol and fauc 213
| Article | Year |
|---|---|
Return of D
Topics: Animals; Drug Discovery; Humans; Ligands; Molecular Targeted Therapy; Neoplasms; Parkinson Disease; Receptors, Dopamine D4; Small Molecule Libraries; Substance-Related Disorders | 2017 |
2 other study(ies) available for haloperidol and fauc 213
| Article | Year |
|---|---|
Modeling the similarity and divergence of dopamine D2-like receptors and identification of validated ligand-receptor complexes.
Topics: Amino Acid Sequence; Animals; Cattle; Conserved Sequence; Dopamine Antagonists; Humans; Ligands; Models, Molecular; Molecular Sequence Data; Mutation; Protein Conformation; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Dopamine D4; Rhodopsin; Sequence Alignment; Spiperone | 2005 |
Structure-selectivity investigations of D2-like receptor ligands by CoMFA and CoMSIA guiding the discovery of D3 selective PET radioligands.
Topics: Animals; Benzamides; Fluorine Radioisotopes; In Vitro Techniques; Ligands; Models, Molecular; Molecular Conformation; Piperazines; Positron-Emission Tomography; Quantitative Structure-Activity Relationship; Radioligand Assay; Radiopharmaceuticals; Receptors, Dopamine D2; Receptors, Dopamine D3; Swine | 2007 |